Suppr超能文献

埃索美拉唑可减少健康志愿者饮用啤酒后的胃食管反流。

Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers.

作者信息

Franke Andreas, Hepp Caroline, Harder Hermann, Beglinger Christoph, Singer Manfred V

机构信息

Department of Medicine II (Gastroenterology, Hepatology and Infectious Diseases), University Hospital of Heidelberg at Mannheim, Mannheim, Germany.

出版信息

Scand J Gastroenterol. 2008;43(12):1425-31. doi: 10.1080/00365520802105110.

Abstract

OBJECTIVE

Patients with gastroesophageal reflux disease (GERD) are advised to avoid alcoholic beverages since alcohol consumption induces gastroesophageal reflux in healthy volunteers and increases it in patients with GERD. Proton-pump inhibitors (PPIs) are frequently administered for reflux symptoms but their effect on gastroesophageal reflux after alcohol consumption has not yet been fully studied. The aim of the present study was therefore to investigate the effect of esomeprazole, an S-enantiomer of omeprazole, on gastroesophageal reflux after beer consumption.

MATERIAL AND METHODS

In this placebo-controlled, double-blind, crossover study, 16 healthy male volunteers received 20 mg esomeprazole daily for one week. On day 7, in an acute experiment, the subjects then consumed 500 ml beer within 5 min. Subsequently, gastroesophageal reflux was monitored by pH-metry over a period of 3 h. In addition, gastric emptying was measured by ultrasonography and blood concentrations of ethanol, cholecystokinin and gastrin were determined.

RESULTS

Gastroesophageal reflux was significantly (p=0.001) reduced by 93% after treatment with esomeprazole (0.2%, median percentage of time pH<4) as compared to placebo (2.6%), but gastric emptying, blood ethanol and cholecystokinin concentrations were not significantly different after esomeprazole treatment. Plasma gastrin levels were significantly (p=0.0003) higher after esomeprazole (98.6+/-19.7 pg/ml) than after placebo (22.7+/-3.8 pg/ml) before beer consumption. However, there was no difference in the increase in plasma gastrin after beer consumption between the esomeprazole treatment and placebo.

CONCLUSIONS

Esomeprazole significantly reduces gastroesophageal reflux after beer consumption in healthy volunteers. Gastric emptying of beer is not prolonged after treatment with esomeprazole, although compared with placebo, this PPI induced significantly higher plasma gastrin concentrations. Moderate alcohol consumption does not worsen gastroesophageal reflux when a PPI is administered.

摘要

目的

胃食管反流病(GERD)患者被建议避免饮用酒精饮料,因为饮酒会在健康志愿者中诱发胃食管反流,并使GERD患者的反流情况加重。质子泵抑制剂(PPIs)常用于治疗反流症状,但其对饮酒后胃食管反流的影响尚未得到充分研究。因此,本研究的目的是调查奥美拉唑的S-对映体埃索美拉唑对饮用啤酒后胃食管反流的影响。

材料与方法

在这项安慰剂对照、双盲、交叉研究中,16名健康男性志愿者每天服用20毫克埃索美拉唑,持续一周。在第7天,进行一项急性实验,受试者在5分钟内饮用500毫升啤酒。随后,通过pH值测定法监测胃食管反流3小时。此外,通过超声检查测量胃排空情况,并测定血液中乙醇、胆囊收缩素和胃泌素的浓度。

结果

与安慰剂组(2.6%)相比,埃索美拉唑治疗后(pH<4的时间中位数百分比为0.2%),胃食管反流显著减少(p=0.001),减少了93%,但埃索美拉唑治疗后胃排空、血液乙醇和胆囊收缩素浓度无显著差异。饮用啤酒前,埃索美拉唑组(98.6±19.7皮克/毫升)的血浆胃泌素水平显著高于安慰剂组(22.7±3.8皮克/毫升)(p=0.0003)。然而,埃索美拉唑治疗组和安慰剂组饮用啤酒后血浆胃泌素的升高幅度没有差异。

结论

埃索美拉唑可显著降低健康志愿者饮用啤酒后的胃食管反流。埃索美拉唑治疗后啤酒的胃排空时间没有延长,尽管与安慰剂相比,这种质子泵抑制剂会导致血浆胃泌素浓度显著升高。服用质子泵抑制剂时,适度饮酒不会使胃食管反流恶化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验